Voloridge Investment Management
XENT

Voloridge Investment Management’s Intersect ENT, Inc XENT Stock Holding History

Voloridge Investment Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,126
Closed -$602K – 1934
2021
Q3 		$602K Buy
+22,126
New +$547K ﹤0.01% 1418
2021
Q1 		– Sell
-60,610
Closed -$1.39M – 1741
2020
Q4 		$1.39M Sell
60,610
-24,546
-29% -$467K 0.01% 862
2020
Q3 		$1.39M Buy
+85,156
New +$1.54M 0.01% 836
2020
Q1 		– Sell
-15,774
Closed -$393K – 1505
2019
Q4 		$393K Buy
+15,774
New +$320K 0.01% 867

Other funds holding XENT

VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
KLCMU
Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Voloridge Investment Management's XENT Position: Q4 2021 in Review

Voloridge Investment Management sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 22,126 shares — an estimated $602K sold.

Voloridge Investment Management first reported a position in XENT in Q4 2019 and held it in 4 quarters. The position peaked at $1.39M in Q3 2020. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.

  • Voloridge Investment Management reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 22,126 Intersect ENT, Inc shares in Q4 2021, an estimated $602K.
  • Voloridge Investment Management first reported a position in Intersect ENT, Inc in Q4 2019 and held it in 4 quarters.
  • Voloridge Investment Management's Intersect ENT, Inc position peaked at $1.39M in Q3 2020.
  • 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.

Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.